William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories
-
Jersey Mike's closes IPO at $23 per share on NYSE
-
William Blair Reiterates Outperform Rating on SPX Technologies (SPXC)
-
Perimeter Solutions Reports Second Quarter 2026 Financial Results
-
William Blair Downgrades GoDaddy Inc (GDDY) to Market Perform
-
Jersey Mike's prices IPO at $23 per share on NYSE as JMKE
-
Jersey Mike’s Announces Pricing of Its Initial Public Offering
-
Reformation prices IPO at $15 per share on NYSE
-
Reformation Announces Pricing of Initial Public Offering
-
Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
William Blair on Parsons Corp. (PSN): 'Guidance Cut on Program Write-Downs'
-
William Blair on Lennox International (LII): 'Our initial view is negative'
-
CAIS Welcomes New Strategic Investors, Valuing the Company at Over $2 Billion
-
William Blair Downgrades CoStar Group (CSGP) to Market Perform
-
William Blair Starts Rapport Therapeutics (RAPP) at Outperform
-
William Blair Starts Neutron Holdings (LIME) at Outperform
-
Form D William Blair PWM Opport
-
William Blair Reiterates Market Perform Rating on AMD (AMD)
-
William Blair Starts Mama’s Creations (MAMA) at Outperform
-
Lyntris files for IPO, plans to list on NYSE under "LYNX"
-
Lyntris Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering
-
William Blair Starts Core & Main Inc. (CNM) at Market Perform
-
William Blair Downgrades Pegasystems (PEGA) to Market Perform
-
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife
-
GE Vernova misses core profit estimates as Wind weakness persists
-
Many US patients opt for obesity drug injections, defying some expectations
-
William Blair Investment Management Launches Global Leaders Select Strategy, Appoints Chandan Khanna as Co-Portfolio Manager
-
William Blair comments on Fortinet (FTNT) and Intel (INTC) strategic collaboration
-
William Blair: 'cybersecurity is now perceived as a beneficiary of AI'
-
Paine Schwartz Partners Announces Sale of Lyons Magnus to Truelink Capital
-
Truelink Capital Completes Acquisition of Lyons Magnus, a Leading Developer and Manufacturer of Specialty Ingredients, Beverage, and Nutrition Solutions
-
Reformation launches IPO on NYSE at $15-$17 per share
-
Reformation Launches Initial Public Offering
-
Reformation files for 14.06M share IPO on NYSE at $15-$17 per share
-
Greenbelt Capital Partners Invests in Bowe & Gant, a Leading Northeast Electrical and Energy Infrastructure Services Provider
-
Jersey Mike's launches IPO roadshow, targets NYSE listing as JMKE
-
Jersey Mike's Announces Launch of Initial Public Offering
-
William Blair Upgrades BJ's Restaurants (BJRI) to Outperform
-
Abbott raises 2026 profit forecast on strength in diagnostics, medical devices
-
LKCM Headwater to take Distribution Solutions Group private at $35 per share
-
Distribution Solutions Group to Be Taken Private by Affiliates of LKCM Headwater Investments for $35.00 Per Common Share in Cash
-
Standard Nuclear prices IPO at $15 per share on NYSE
-
Standard Nuclear Announces Pricing of its Initial Public Offering
-
William Blair Hires Head of Biopharma Investment Banking, based in New York
-
William Blair on Progressive Corp. (PGR): 'a likely challenging near-term environment'
-
William Blair: 'We are hesitant to chase PayPal shares higher'
-
Standard Nuclear slashes IPO plans to 10 million shares
-
William Blair: 'We think investors should stay involved in Coinbase'
-
Stripe, Advent offer to buy PayPal for more than $53 billion, sources say
-
Alto Neuroscience prices $100M stock offering to fund depression trial
-
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock

